peripheral blood
-
not specified
RNA-seq; RT-qPCR; Clinical Sample Validation
circCSNK1G3 is significantly decreased in malignant cells from both t(14;19) CLL and CLL without t(14;19) compared with healthy B cells, representing a common circRNA dysregulation in CLL.
0.3588
Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study.
combined biological and clinical study